Ginseng is a traditional Chinese medicine with a long medicinal history.Ginsenoside is the main compo⁃nent of ginseng,among which the ginsenoside-Rg3 possess higher medicinal value.The pharmacological studies reported...Ginseng is a traditional Chinese medicine with a long medicinal history.Ginsenoside is the main compo⁃nent of ginseng,among which the ginsenoside-Rg3 possess higher medicinal value.The pharmacological studies reported that the ginsenoside-Rg3 exhibit a variety of pharmacological actions.For example,the ginsenoside-Rg3 exhibit an effective inhibitory effect against cancer and induce apoptosis,such as glioma,lung cancer,liver cancer,breast cancer,ovarian cancer,cervical cancer and so on.The anti-cancer effect will be significantly increased by combinning chemotherapy drugs with ginsenoside-Rg3.In addition,ginsenoside-Rg3 can reduce the side effects of chemotherapy drugs,such as cardiotoxicity and nephrotoxicity.Furthermore,ginsenoside-Rg3 could reverse the multidrug resistance of cancer cells against anticancer drugs.What′s more,ginsenoid-Rg3 has several other pharmacological actions as follows.At first,ginsenoid-Rg3 appears to anti-fatigue effect by reversing the dopamine reduction induced by fatigue.Secondly,ginsenoid-Rg3 can reverse chemical-induced memory damage and improve memory to exert neuroprotective effect.Finally,ginsenoid-Rg3 can improve mitochondrial function and insulin tolerance in skeletal muscle,suggesting that ginsenoid-Rg3 can be used as a hypoglycemic drug.In this review,I present an overview of the pharmacological actions of ginsenoside-Rg3 to provide theoretical guidance for further development and utilization of ginsenoside-Rg3.展开更多
OBJECTIVE To review the application of nanoparticles modified with angiopep-2,providing theoretical guidance for the diagnosis and treatment of glioma. METHODS According to domestic and foreign research reports of nan...OBJECTIVE To review the application of nanoparticles modified with angiopep-2,providing theoretical guidance for the diagnosis and treatment of glioma. METHODS According to domestic and foreign research reports of nanoparticles modified with angiopep-2 in recent years,the application in the diagnosis and treatment of glioma was summarized and analyzed. RESULTS Angiopep-2 can be modified to the surface of nanoparticles loaded with imaging agents or chemotherapeutic agents,which can significantly improve the imaging effect of glioma and achieve targeted drug delivery. CONCLUSION Angiopep-2 exhibits a high brain penetration capability in blood brain barrier and in glioma cells. The nanoparticles modified with angiopep-2 can delivery various imaging agents and chemotherapeutic agents to glioma cells,the dual-targeting delivery systems can provide theoretical guidance for the diagnosis and treatment of glioma.展开更多
Background Cyclin B1 （CLB1） is necessary for mitotic initiation in mammalian cells and plays important roles in cancer development. Therefore, a potential strategy in cancer therapy is to suppress the activity of CL...Background Cyclin B1 （CLB1） is necessary for mitotic initiation in mammalian cells and plays important roles in cancer development. Therefore, a potential strategy in cancer therapy is to suppress the activity of CLB1 by delivering antisense constructs of CLB1 into tumor cells. In previous CLB1 studies, antisense constructs with a short half life were often used and these constructs might not persistently inhibit CLB1. Methods We successfully created a recombinant plasmid encoding the full-length antisense cDNA of mouse cyclin B1 （AS-mCLB1） and transfected this construct to the murine Lewis lung carcinoma （LL/2） and CT-26 colon carcinoma （CT-26） cells. We isolated clones of LL/2 and CT-26 transfectants with stable expression of AS-mCLB1. Reverse transcriptional polymerase chain reaction （RT-PCR） and Western blot were applied to detect the expression of the mRNA and protein levels of CLB1. To further test the efficacy of this strategy in vivo, AS-mCLBl-expressing LL/2 and CT-26 transfectants were implanted into mice. Results We found the expression of the mRNA and protein levels of CLB1 decrease in these transfectants. The inhibition of CLB1 caused prominent G1 arrest, abnormal morphology, retarded cell growth and an increase in apoptosis. In AS-mCLBl-expressing LL/2 and CT-26 transfectants implanted mice, tumorigenicity was effectively suppressed compared with the controls. In addition, the expression of AS-mCLB1 also significantly increases the survival duration of implanted animals. Conclusion AS-mCLB1 is likely to be useful in future cancer therapy, which may be associated with its ability to down-regulate the expression of CLB1 and then induce G1 arrest and apoptosis in tumor cells.展开更多
文摘脑胶质瘤是常见的原发性颅内肿瘤,其难以治愈的主要原因为血脑脊液屏障（blood-cerebrospinal fluid barrier,blood-CSF barrier）的存在阻碍了化疗药物进入脑内,大大降低了有效药物浓度。此外,肉眼可见的肿瘤已经处于中后期,失去了最佳的治疗时机。Angiopep-2为低密度脂蛋白受体相关蛋白（low density lipoprotein receptor related protein,LRP）的配体,血脑脊液屏障和胶质瘤细胞表面都高度表达LRP受体。Angiopep-2具有靶向性,将其修饰到装载化疗药物和显像剂的纳米粒子表面,可以实现靶向释药,提高胶质瘤成像效果。该文综述了以Angiopep-2修饰的装载不同药物的纳米系统在胶质瘤中的应用,为胶质瘤的诊断和治疗提供了思路和方法。
文摘Ginseng is a traditional Chinese medicine with a long medicinal history.Ginsenoside is the main compo⁃nent of ginseng,among which the ginsenoside-Rg3 possess higher medicinal value.The pharmacological studies reported that the ginsenoside-Rg3 exhibit a variety of pharmacological actions.For example,the ginsenoside-Rg3 exhibit an effective inhibitory effect against cancer and induce apoptosis,such as glioma,lung cancer,liver cancer,breast cancer,ovarian cancer,cervical cancer and so on.The anti-cancer effect will be significantly increased by combinning chemotherapy drugs with ginsenoside-Rg3.In addition,ginsenoside-Rg3 can reduce the side effects of chemotherapy drugs,such as cardiotoxicity and nephrotoxicity.Furthermore,ginsenoside-Rg3 could reverse the multidrug resistance of cancer cells against anticancer drugs.What′s more,ginsenoid-Rg3 has several other pharmacological actions as follows.At first,ginsenoid-Rg3 appears to anti-fatigue effect by reversing the dopamine reduction induced by fatigue.Secondly,ginsenoid-Rg3 can reverse chemical-induced memory damage and improve memory to exert neuroprotective effect.Finally,ginsenoid-Rg3 can improve mitochondrial function and insulin tolerance in skeletal muscle,suggesting that ginsenoid-Rg3 can be used as a hypoglycemic drug.In this review,I present an overview of the pharmacological actions of ginsenoside-Rg3 to provide theoretical guidance for further development and utilization of ginsenoside-Rg3.
文摘OBJECTIVE To review the application of nanoparticles modified with angiopep-2,providing theoretical guidance for the diagnosis and treatment of glioma. METHODS According to domestic and foreign research reports of nanoparticles modified with angiopep-2 in recent years,the application in the diagnosis and treatment of glioma was summarized and analyzed. RESULTS Angiopep-2 can be modified to the surface of nanoparticles loaded with imaging agents or chemotherapeutic agents,which can significantly improve the imaging effect of glioma and achieve targeted drug delivery. CONCLUSION Angiopep-2 exhibits a high brain penetration capability in blood brain barrier and in glioma cells. The nanoparticles modified with angiopep-2 can delivery various imaging agents and chemotherapeutic agents to glioma cells,the dual-targeting delivery systems can provide theoretical guidance for the diagnosis and treatment of glioma.
基金This work was supported by the funds from the Natural Science Foundation of Zhejiang Province, China （No. Y207353） and Science Foundation of Zhejiang Province, China for Postdoctors （No. 2006-bsh-34）.
文摘Background Cyclin B1 （CLB1） is necessary for mitotic initiation in mammalian cells and plays important roles in cancer development. Therefore, a potential strategy in cancer therapy is to suppress the activity of CLB1 by delivering antisense constructs of CLB1 into tumor cells. In previous CLB1 studies, antisense constructs with a short half life were often used and these constructs might not persistently inhibit CLB1. Methods We successfully created a recombinant plasmid encoding the full-length antisense cDNA of mouse cyclin B1 （AS-mCLB1） and transfected this construct to the murine Lewis lung carcinoma （LL/2） and CT-26 colon carcinoma （CT-26） cells. We isolated clones of LL/2 and CT-26 transfectants with stable expression of AS-mCLB1. Reverse transcriptional polymerase chain reaction （RT-PCR） and Western blot were applied to detect the expression of the mRNA and protein levels of CLB1. To further test the efficacy of this strategy in vivo, AS-mCLBl-expressing LL/2 and CT-26 transfectants were implanted into mice. Results We found the expression of the mRNA and protein levels of CLB1 decrease in these transfectants. The inhibition of CLB1 caused prominent G1 arrest, abnormal morphology, retarded cell growth and an increase in apoptosis. In AS-mCLBl-expressing LL/2 and CT-26 transfectants implanted mice, tumorigenicity was effectively suppressed compared with the controls. In addition, the expression of AS-mCLB1 also significantly increases the survival duration of implanted animals. Conclusion AS-mCLB1 is likely to be useful in future cancer therapy, which may be associated with its ability to down-regulate the expression of CLB1 and then induce G1 arrest and apoptosis in tumor cells.
